Our Team
Our team comprises of accomplished scientist-entrepreneurs with novel foresight to imagine innovative solutions and products.
About 'BRETT'
Brett Schrand, PhD
Dr. Brett Schrand is the Vice President of Translational Medicine at Cell BioEngines. He is an innovative scientist that brings more than 10 years of combined experience in the academic and industry settings in the fields of cancer immunology and drug development. Prior to joining Cell BioEngines, Dr. Schrand worked at TCR2 Therapeutics (
Dr. Brett Schrand is the Vice President of Translational Medicine at Cell BioEngines. He is an innovative scientist that brings more than 10 years of combined experience in the academic and industry settings in the fields of cancer immunology and drug development. Prior to joining Cell BioEngines, Dr. Schrand worked at TCR2 Therapeutics (NASDAQ:TCRR) and Wave Life Sciences (NASDAQ: WVE) helping advance lead candidates and drive drug development programs.
Dr. Schrand received his PhD from the University of Miami in 2014. While performing research in the lab of Dr. Eli Gilboa, Dr. Schrand developed his knowledge base of immuno-oncology and the tumor microenvironment and applied this to generate novel approaches to enhance anti-tumor immunity. His expertise in immuno-oncology led to multiple patent applications and high impact publications and highlights his passion to one day be able to help more cancer patients.